Evidence map›Paper›PMID 40560033›Full record

ArticlePharmacy (Basel, Switzerland)2025

Pharmacists' Perceptions of 3D Printing and Bioprinting as Part of Personalized Pharmacy: A Cross-Sectional Pilot Study in Bulgaria.

Anna Mihaylova, Antoniya Yaneva, Dobromira Shopova, Petya Kasnakova, Stanislava Harizanova, Nikoleta Parahuleva, Rumyana Etova, Ekaterina Raykova, Mariya Semerdzhieva, Desislava Bakova

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmacy (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anna MihaylovaDepartment of Health Care Management, Faculty of Public Health, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.ORCID 0000-0002-7674-6074
Antoniya YanevaDepartment of Medical Informatics, Biostatistics and e-Learning, Faculty of Public Health, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
Dobromira ShopovaDepartment of Prosthetic Dentistry, Faculty of Dental Medicine, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.ORCID 0000-0003-1287-930X
Petya KasnakovaDepartment of Health Care Management, Faculty of Public Health, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
Stanislava HarizanovaDepartment of Hygiene, Faculty of Public Health, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.ORCID 0000-0003-4769-6685
Nikoleta ParahulevaDepartment of Obstetrics and Gynaecology, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
Rumyana EtovaDepartment of Epidemiology and Disaster Medicine, Faculty of Public Health, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
Ekaterina RaykovaDepartment of Health Care Management, Faculty of Public Health, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
Mariya SemerdzhievaDepartment of Health Care Management, Faculty of Public Health, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
Desislava BakovaDepartment of Health Care Management, Faculty of Public Health, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in pharmaceutical technology have positioned 3D printing and bioprinting as promising tools for developing personalized drug therapies. These innovations may redefine compounding practices by enabling precise, patient-specific drug formulations. Evaluating pharmacists' readiness to adopt such technologies is therefore becoming increasingly important.

Indexed as

3D printingbioprintingpersonalized medicinepersonalized pharmacypharmacists

Identifiers

PMID40560033
PMCPMC12196576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.